<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.46624/ajptr.2018.v8.i1.012</article-id>
      <article-id pub-id-type="publisher-id">AJPTR81012</article-id>
      <title-group>
        <article-title>Insilico Evaluation and Antioxidant Activity of [(2E)-7 Hydroxy-4-Methyl-2H-Chromen-2-Ylidene] Amino Derivatives</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Anupama</surname>
            <given-names>B.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>lakshmi</surname>
            <given-names>KNV Chenchu</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>vani</surname>
            <given-names>R. Satya</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>kotaiah</surname>
            <given-names>A. Bala</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2018-02-01">
        <month>02</month>
        <day>01</day>
        <year>2018</year>
      </pub-date>
      <volume>8</volume>
      <issue>1</issue>
      <abstract>
        <p>Coumarin Schiff bases (1-14) synthesized by microwave irradiation method, were evaluated by insilico techniques and for their antioxidant activity by ferric reducing antioxidant power (FRAP) assay. The results from insilico techniques showed that all the compounds exhibit drug likeness satisfying Lipinski rule of five having the ability to behave as drugs. These findings revealed that they are active nuclear receptor, GPCR ligand and enzyme inhibitors. Insilico OSIRIS predictions indicate that all the compounds suffer from teratogenic effect, compounds 9, 14 possesses mutagenic toxicity. OCHEM results clearly indicate that they are inhibitors of CYP1A2 a subtype of cytochrome P450. Compound 8 gave FRAP value nearer to the standard. The study provides a good scope for further development of novel targeted molecules.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Microwave irradiation</kwd>
        <kwd>insilico</kwd>
        <kwd>FRAP</kwd>
        <kwd>OCHEM</kwd>
        <kwd>OSIRIS.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
